Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Chen

Showing results (191-200 of 274) with videos related to

Pageof 28
Sort By:
Brain : a Journal of Neurology|March 3, 2023
Pathological combinations in neurodegenerative disease are heterogeneous and disease-associatedJohn L Robinson, Sharon X Xie, Daniel R Baer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2016
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working GroupLawrence H Schwartz, Lesley Seymour, Saskia Litière, et al.
Investigational New Drugs|March 26, 2010
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortiumDeborah A Bradley, Stephanie Daignault, Charles J Ryan, et al.
Molecular Neurodegeneration|April 9, 2022
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degenerationAlba Cervantes González, David J Irwin, Daniel Alcolea, et al.
Neurology|February 23, 2018
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disordersDavid J Irwin, Sharon X Xie, David Coughlin, et al.
Annals of Neurology|July 25, 2022
Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral SclerosisKatheryn A Q Cousins, Leslie M Shaw, Sanjana Shellikeri, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2016
RECIST 1.1-Update and clarification: From the RECIST committeeLawrence H Schwartz, Saskia Litière, Elisabeth de Vries, et al.
Neurology. Clinical Practice|April 12, 2021
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar DegenerationJiasi Vicky Zhang, David J Irwin, Kaj Blennow, et al.
Gynecologic Oncology|November 12, 2019
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancerKathleen N Moore, Austin Miller, Katherine M Bell-McGuinn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.
Pageof 28

Showing results (191-200 of 274) with videos related to

Sort By:
Pageof 28
Brain : a Journal of Neurology|March 3, 2023
Pathological combinations in neurodegenerative disease are heterogeneous and disease-associatedJohn L Robinson, Sharon X Xie, Daniel R Baer, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2016
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working GroupLawrence H Schwartz, Lesley Seymour, Saskia Litière, et al.
Investigational New Drugs|March 26, 2010
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortiumDeborah A Bradley, Stephanie Daignault, Charles J Ryan, et al.
Molecular Neurodegeneration|April 9, 2022
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degenerationAlba Cervantes González, David J Irwin, Daniel Alcolea, et al.
Neurology|February 23, 2018
CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disordersDavid J Irwin, Sharon X Xie, David Coughlin, et al.
Annals of Neurology|July 25, 2022
Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral SclerosisKatheryn A Q Cousins, Leslie M Shaw, Sanjana Shellikeri, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2016
RECIST 1.1-Update and clarification: From the RECIST committeeLawrence H Schwartz, Saskia Litière, Elisabeth de Vries, et al.
Neurology. Clinical Practice|April 12, 2021
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar DegenerationJiasi Vicky Zhang, David J Irwin, Kaj Blennow, et al.
Gynecologic Oncology|November 12, 2019
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancerKathleen N Moore, Austin Miller, Katherine M Bell-McGuinn, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.
Pageof 28